Sanofi ADR
NASDAQ: SNY
$47.82
-$1.69 (-3.4%)
Closing Price on November 14, 2024
SNY Articles
Genzyme Corporation (NASDAQ: GENZ) is getting closer to capitulating to the offer to be acquired by Sanofi-Aventis (NYSE: SNY). At issue this morning is that Genzyme has agreed to open its books to...
Published:
Last Updated:
Investors have tried for years to follow the strategy of Warren Buffett, considered by many to be the greatest investor in history. That’s ironic given how little he seems to care about ups and...
Published:
Last Updated:
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) has shown its latest holdings as of the close on September 30, 2010. The changes were big on the first two lists but more static on the Third list except...
Published:
Last Updated:
The Sanofi-Aventis (NYSE: SNY) acquisition attempt of Genzyme Corp. (NASDAQ: GENZ) is taking a turn in a strange direction. The company is holding out for more than the $69.00 cash offer on the...
Published:
Last Updated:
The proposed merger and acquisition of Genzyme Corporation (NASDAQ: GENZ) by Sanofi-Aventis (NYSE: SNY) is about to get interesting. There is a building collective thought that a higher bid price...
Published:
Last Updated:
A lot of companies are working on developing microbes to eat something ordinary and expel something extraordinary, like diesel fuel or methane or butanol. Laboratory scale projects have all proved...
Published:
Biotech and BioHealth stocks are on the move today and there is more news in the emerging sector than there has been on a single day in months and months. The news is not even on any of the...
Published:
Last Updated:
The cast of characters in this week’s Unusual Suspects is not any ordinary group of companies. There are many key stocks to watch for investors that have carryover issues from last week or which...
Published:
Last Updated:
Reuters: The Bank of Japan eased policy to fight a rise in the yen. Reuters: Obama said the economy is not growing fast enough. Reuters: Intel (NASDAQ: INTC) will buy Infineon’s mobile...
Published:
Berkshire Hathaway Inc. (NYSE: BRK-B, BRK-A) has shown its latest holdings as of the close on June 30, 2010. These have been broken down into 3 groups of ‘A to G’ and ‘H to R’ and ‘S to...
Published:
Last Updated:
Genzyme Corporation (NASDAQ: GENZ) still has an incredible merger ‘deal premium’ associated with it over a pending Sanofi-Aventis (NYSE: SNY) buyout. Genzyme’s troubles have left it...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Thursday morning: Agrium (NYSE: AGU) has seen targets raised at CIBC, Canaccord, and...
Published:
Last Updated:
All of the freshest reports have the Genzyme Corporation (NASDAQ: GENZ) buyout discussions between Sanofi-Aventis (NYSE: SNY) as being a friendly merger. The first discussions noted by the WSJ were...
Published:
Last Updated:
These are some of this Monday’s top analyst upgrades and downgrades seen from Wall Street research calls: American Electric Power (NYSE: AEP) Started as Outperform at Wells Fargo. Central European...
Published:
Last Updated:
Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in buying the company. The WSJ reports that the large drug giant has approached...
Published:
Last Updated: